Trinity Biotech (TRIB) Gross Margin (2009 - 2024)
Trinity Biotech (TRIB) posted Gross Margin of 30.76% for Q4 2024, down 12.2% sequentially from 35.03% in Q3 2024, and down 325.0% YoY from 13.67% in Q1 2024.
Trinity Biotech (TRIB) Gross Margin (2009 - 2024) Analysis & Trends
Trinity Biotech has reported Gross Margin for 16 years, with the latest figure at 30.76% in Q4 2024.
- Quarterly Gross Margin fell 325.0% year-over-year to 30.76% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 34.83% (up 61.0% YoY) and the FY2025 annual result came in at 38.57%, up 374.0% from the prior year.
- Gross Margin retreated to 30.76% in Q4 2024 per TRIB's latest filing, from 35.03% in the prior quarter.
- Over five years, Gross Margin peaked at 52.4% in Q3 2020 and troughed at 2.1% in Q3 2022.
- A 5-year average of 36.84% and a median of 37.31% in 2021 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2023: Gross Margin slumped 3835 bps in 2022, then soared 2707 bps in 2023.
- Over 5 years, Gross Margin stood at 47.79% in 2020, then declined by 22 bps to 37.08% in 2021, then slipped by 8 bps to 34.18% in 2022, then slipped by 0 bps to 34.01% in 2023, then retreated by 10 bps to 30.76% in 2024.
- According to Business Quant data, Gross Margin over the past three periods registered 30.76%, 35.03%, and 36.19% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.84% |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 30.76% |
| Sep 30, 2024 | 35.03% |
| Jun 30, 2024 | 36.19% |
| Mar 31, 2024 | 37.55% |
| Dec 31, 2023 | 34.01% |
| Sep 30, 2023 | 29.16% |
| Jun 30, 2023 | 36.19% |
| Mar 31, 2023 | 37.58% |
| Dec 31, 2022 | 34.18% |
| Sep 30, 2022 | 2.10% |
| Jun 30, 2022 | 36.20% |
| Mar 31, 2022 | 38.16% |
| Dec 31, 2021 | 37.08% |
| Sep 30, 2021 | 40.45% |
| Jun 30, 2021 | 42.67% |
| Mar 31, 2021 | 42.64% |
| Dec 31, 2020 | 47.79% |
| Sep 30, 2020 | 52.40% |
| Jun 30, 2020 | 42.88% |
| Mar 31, 2020 | 43.80% |